insights_auto
Why is DNA up १४.३४%?
Dive Deeperchevron_right
DNA:NYSE
Ginkgo Bioworks Holdings Inc
US$ ११.९६
arrow_upward
+१४.३४%(+१.५०) 1D
US$ १२.००
arrow_upward
+०.३३% (+०.०४०)bedtimeAfter hours
Closed: सेप्टेम्बर २९, १६:००:०३ GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
US$ १०.५४
High
US$ १२.२७
Low
US$ १०.५३
Mkt. cap
७६.९५ करोड
Avg. vol.
१४.८० लाख
Volume
०.००
52-wk high
US$ १७.५८
52-wk low
US$ ५.३७
EPS
-US$ ५.००
Beta
१.७६
Shares outstanding
५.५४ करोड
No. of employees
४८५
Open
US$ १०.५४
High
US$ १२.२७
Low
US$ १०.५३
Mkt. cap
७६.९५ करोड
Avg. vol.
१४.८० लाख
Volume
०.००
52-wk high
US$ १७.५८
52-wk low
US$ ५.३७
EPS
-US$ ५.००
Beta
१.७६
Shares outstanding
५.५४ करोड
No. of employees
४८५
News stories
From web sources and news partners
Stock Titan
·
२० घण्टा पहिले
AbbVie and Takeda can use AI models without revealing sequences to other members
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees४८५
Founded२००८
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websiteginkgo.bio